CYTOSORBENTS CORPORATION (CTSO) Capital expenditures 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$164,000FY2025 · since FY2016: $140,724 → $164,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $164,000 | -42.3% |
| FY2024 | $284,000 | -47.2% |
| FY2023 | $538,115 | -91.2% |
| FY2022 | $6.1M | +67.2% |
| FY2021 | $3.6M | +414.0% |
| FY2020 | $708,395 | +1.5% |
| FY2019 | $698,165 | +3.9% |
| FY2018 | $671,970 | -32.2% |
| FY2017 | $990,673 | +604.0% |
| FY2016 | $140,724 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice